Search

everythinglearnresearchcommunity

for

Search:↓

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

The document concludes that early and accurate diagnosis of hair loss on the top of the scalp in Black men is important to distinguish CCCA from other types of hair loss.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Female pattern hair loss diagnosis is challenging and should use dermoscopy and histopathology instead of pattern recognition, as hormones may not always be the cause.

Adapted classification better assesses male pattern hair loss and its link to heart disease.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

N-acetyl-cysteine improves hair growth and is safe for treating early male hair loss.

Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.

Hair loss common in Australia; men affected earlier, more often than Asians; women less concerned.

Hair loss linked to higher heart disease risk in both men and women.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Androgens may block hair growth signals, targeting this could treat hair loss.

AGA more common in men, increases with age, linked to family history, hypertension, dyslipidemia, and smoking.

Dutasteride is more effective than finasteride at increasing hair count and reversing hair thinning in men with hair loss, but both have similar side effects.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

At least 87% of Indian men experience hair loss, with type II being most common and severity increasing with age.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Most men with hair loss worry, try self-treatments, and delay doctor visits due to cost, uncertainty, and embarrassment.

Men with androgenetic alopecia have oilier and less hydrated scalps, especially in sensitive areas.

A simplified method was introduced to diagnose most hair loss types by examining the patient's history and scalp, with some cases needing further tests.

The microenvironment, especially mechanical forces, plays a crucial role in hair growth and could lead to new treatments for hair loss.

Finasteride helps female-pattern hair loss.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

Scarring hair loss found in female pattern; biopsy needed for diagnosis.

Hair loss link to COVID-19 severity likely due to other factors.

PRP injections may slightly improve hair density and count for male hair loss, but more research is needed.

Androgenetic alopecia, or hair loss, is most common in people in their 30s, can start early, is often inherited, and may be influenced by factors like hormones and scalp health.

Frequent use of hair straighteners can cause hair loss similar to scarring alopecia in young Turkish women.